do not prove clinical benefit in humans
Ozempic (semaglutide) is an FDA-approved medication specifically for managing type 2 diabetes and is not intended for weight loss purposes
Endogenous hyperinsulinemia may cause weight gain and obesity [30], and treatment with insulin causes substantial weight gain, and may even increase cardiovascular risk [31]
48 The human GSTP1 gene exists as two functionally different variants, with both variants having documented nucleotide transitions from isoleucine to valine at codon 105 (AG) and alanine to Val at 114 (CT)
(57) reported that UCP-2 gene expression in subcutaneous adipose tissue from obese individuals was significantly lower compared to that from lean ones, whereas Millet et al
In addition to dietary intake, malabsorption conditions like celiac disease, atrophic gastritis, and inflammatory bowel diseases, all of autoimmune nature and frequently associated with autoimmune thyroid diseases, must be taken into account when vitamin B12 requirements are evaluated [97,98,99]
